Transition pathway to support cancer patients after hospital discharge
Etude de faisabilité d'un Parcours de Transition à la Sortie d'Hospitalisation complète en Oncologie - Etude Pilote Monocentrique
Centre Hospitalier Universitaire de Nīmes · NCT07256444
This project will try the OncoCare transition program, using patient-reported symptom check-ins and follow-up calls to help adults with cancer after they leave the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nīmes (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Nîmes) |
| Trial ID | NCT07256444 on ClinicalTrials.gov |
What this trial studies
This observational feasibility study follows adults admitted to an oncology ward for at least 48 hours who are discharged home and able to use a connected device. Participants use electronic patient-reported outcome (ePRO) tools to report symptoms after discharge and receive follow-up contacts from clinical staff as part of the OncoCare transition program. The study will collect feasibility metrics alongside patient-reported outcomes, emergency department visits, and readmissions in the weeks after discharge. Results will inform whether this pathway can be scaled into routine oncology discharge care.
Who should consider this trial
Good fit: Adults hospitalized in an oncology unit for at least 48 hours who are discharged home, can give informed consent, read French, and have a smartphone or tablet with internet access are ideal candidates.
Not a fit: Patients discharged to a home care facility, those at end of life, people unable to read French or use a connected device, and those admitted for scheduled outpatient procedures are unlikely to benefit.
Why it matters
Potential benefit: If successful, the program could catch post-discharge problems earlier, reduce emergency visits and readmissions, and improve patients' quality of life.
How similar studies have performed: Similar uses of patient-reported outcomes and post-discharge telephone follow-up have reduced emergency visits and improved quality of life in oncology and surgical settings, though the exact OncoCare pathway is a newer application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Adult patient hospitalized in an oncology unit for at least 48 hours. * Patient capable of using a connected device, in possession of a smartphone or tablet, and with an internet connection at home. * Patient discharged from hospital to go home. Exclusion Criteria: * The patient is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Patient considered to be at the end of life. * Patient unable to read and understand French * Patient discharged from hospitalization to a home care facility * Patient having been hospitalized in a full-time inpatient setting for a scheduled procedure (chemotherapy or interventional procedure) * Pregnant, parturient, or breastfeeding
Where this trial is running
Nîmes
- Centre Hospitalier de Nimes — Nîmes, France (RECRUITING)
Study contacts
- Principal investigator: Astrid Basset — CHU de Nimes
- Study coordinator: Astrid Basset
- Email: astrid.basset@chu-nimes.fr
- Phone: 06.24.89.63.27
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer